Race may influence uterine cancer recurrence
In spite of receiving identical care, African Americans are more likely to have a recurrence of uterine cancer than their Caucasian counterparts.
In spite of receiving identical care, African Americans are more likely to have a recurrence of uterine cancer than their Caucasian counterparts, according to researchers at Henry Ford Hospital in Detroit.
In one of the largest retrospective studies of its kind with 750 stage I or II uterine cancer patients, researchers found that despite undergoing a total hysterectomy or a hysterectomy followed by radiation therapy, African American women were more likely to suffer a recurrence than Caucasian women. Median time to recurrence among the group was 1.2 years.
The site of recurrence was primarily vaginal (74%) for those who did not receive radiation therapy. The researchers also found that higher tumor grade and cancer stage, along with age (older than 65 years), were risk factors for uterine cancer recurrence after treatment.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
